A phase 1 study to evaluate the dose, safety and tolerability of a radionuclide therapy (Radspherin®) in patients with platinum sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma with peritoneal carcinomatosis following complete surgical resection

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511851-16-00

Enrollment

Registered

2024-09-20

Start date

2024-09-20

Completion date

2025-09-08

Last updated

2025-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fallopian Tube or Primary Peritoneal Carcinoma With Peritoneal Carcinomatosis, Platinum Sensitive Recurrent Epithelial Ovarian

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Norway, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026